Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The Art of Investing -- Ignore unavailable to you. Want to Upgrade?

To: Sun Tzu who wrote (2524)	11/11/2021 8:48:04 AM
From: Sun Tzu	Read Replies (1) \| Respond to of 10701

Compugen Shares Rise 18% Premarket After Bristol Myers Investment BY Dow Jones & Company, Inc. — 7:59 AM ET 11/11/2021 Compugen Ltd. ( CGEN ) shares rose 18% to $7.41 in premarket trading after the company said Bristol Myers Squibb ( BMY ) completed its $20 million investment. Bristol Myers' investment was in consideration for the issuance of 2.3 million Compugen (CGEN ) shares purchased at $8.57333 a share, representing a 33% premium over the closing price Tuesday. A joint steering committee has been formed to oversee strategic oversight and guidance for the programs run under the collaboration, which will run alongside the existing joint development committee, Compugen ( CGEN ) said. "We value Bristol Myers Squibb's ( BMY ) continued support of Compugen ( CGEN ) and in our evaluation of our DNAM axis hypothesis by testing COM701 in combination with nivolumab as a dual combination and in combination with nivolumab and BMS-986207 as a triple combination targeting PVRIG, PD-1 and TIGIT," Compugen ( CGEN ) Chief Executive Anat Cohen-Dayag said. Write to Chris Wack at chris.wack@wsj.com ===== I feel vendicated fighting the tape on this... Which is something I rarely do. PS. My" fighting the tape "on CGEN means that as of yesterday's close, I am down $36 dollars on a 6,000 share position. So we aren't talking about a war of attrition here. Nonetheless, as I had previously said, I was (and am) willing to buy increasing number of shares on its way down, so long as they progress on their fundamentals.